Phage Display‐Based Discovery of HPV Capsomere‐Specific Antibodies for HPV Process Characterization
Biotechnology Journal · 2026
DOI: 10.1002/biot.70205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2026. Verfasst von Ayotunde Paul Ikujuni und 16 weiteren Autor:innen. Beteiligte Einrichtung: MRL, Merck & Co., Inc., West Point, Pennsylvania, USA. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Capsid Proteins, Antibodies, Viral, Human Papillomavirus Viruses. Die Arbeit nennt 62 Literaturangaben.
Abstract (Originalsprache)
Human papillomaviruses (HPV) are a diverse group of viruses that primarily infect squamous epithelial cells, often leading to proliferative lesions and various cancers. The HPV capsid is formed from the coassembly of two major capsid proteins, L1 and L2. Notably, the L1 protein can self‐assemble into virus‐like particles (VLPs) that exhibit structural and immunological similarities to the native virus capsid. The assembly of L1 proteins into VLPs involves the formation of the critical repeating pentamer subunits known as capsomeres. However, due to high structural similarities, there are no antibodies that can distinguish between capsomeres and VLPs, making it challenging to work with capsomeres. In this study, we generated and characterized capsomere‐specific monoclonal antibodies (mAbs) to probe HPV manufacturing process. We prepared high‐purity Type16 (T16) capsomeres, and used phage display technology to developed mAbs with high affinity for T16 capsomeres. Using immunoassays and biophysical analyses, we demonstrated that these antibodies bind to conformational epitopes on T16 capsomeres but not T16 VLPs. Furthermore, we established an enzyme‐linked immunosorbent assay (ELISA) using one of these antibodies to quantify capsomere in cell lysates. Our findings demonstrate that these capsomere‐specific antibodies are valuable tools for probing HPV process intermediates in order to optimized process development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- MRL, Merck & Co., Inc., West Point, Pennsylvania, USA.
- MRL, Merck & Co., Inc., Rahway, New Jersey, USA.
ORCID-Profile: Ayotunde Paul Ikujuni
Zitieren
APA
Ikujuni, A. P., Banos, C., Daley, S., Gabriel, A., Deng, J. Z., Chang, I. Y., Hartmann, M., Miller, S., Kuster, N., Pan, O. C., Fridman, A., Meyer, B., Winters, M., Trausch, J., Chen, Z., Mukherjee, M., & Grau, B. (2026). Phage Display‐Based Discovery of HPV Capsomere‐Specific Antibodies for HPV Process Characterization. Biotechnology Journal. https://doi.org/10.1002/biot.70205
Vancouver
Ikujuni AP, Banos C, Daley S, Gabriel A, Deng JZ, Chang IY, et al. Phage Display‐Based Discovery of HPV Capsomere‐Specific Antibodies for HPV Process Characterization. Biotechnology Journal. 2026. doi:10.1002/biot.70205
BibTeX
@article{Ikujuni2026,
author = {Ikujuni, Ayotunde Paul and Banos, Christine and Daley, Sara and Gabriel, Adam and Deng, James Z and Chang, Irene Yin-Ting and Hartmann, Michael and Miller, Sean and Kuster, Nathan and Pan, Oscar Chi-Chien and Fridman, Arthur and Meyer, Brian and Winters, Michael and Trausch, Jeremiah and Chen, Zhifeng and Mukherjee, Malini and Grau, Brendan},
title = {Phage Display‐Based Discovery of HPV Capsomere‐Specific Antibodies for HPV Process Characterization},
journal = {Biotechnology Journal},
year = {2026},
doi = {10.1002/biot.70205}
}
EUVIMED